Dopamine agonists and ischemic complications in Parkinson's disease: A nested case-control study

European Journal of Clinical Pharmacology

Volumn 68, Issue 1, 2012, Pages 83-88

  Arbouw, Maurits E L ^a,b,c   Movig, Kris L L ^c   Guchelaar, Henk Jan ^d   Neef, Cees ^e   Egberts, Toine C G ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dopaminergic drugs; Ischemic complications; Parkinson's disease

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; BENZODIAZEPINE; BROMOCRIPTINE; CABERGOLINE; CARDIOVASCULAR AGENT; CONTRACEPTIVE AGENT; DEXFENFLURAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOLINE; ERGOTAMINE; FENFLURAMINE; LEVODOPA; LISURIDE; METHYSERGIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORERGOLINE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EXPOSURE; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PERIPHERAL ISCHEMIA; PHARMACOEPIDEMIOLOGY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DOPAMINE AGONISTS; DRUG PRESCRIPTIONS; ERGOLINES; FEMALE; HOSPITALIZATION; HUMANS; ISCHEMIA; LEVODOPA; MALE; MYOCARDIAL ISCHEMIA; NETHERLANDS; PARKINSON DISEASE; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; RAYNAUD DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 84857038254     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1084-6     Document Type: Article

References (20)

1. F Larrazet C Spaulding HJ Lobreau S Weber F Guerin 1993 Possible bromocriptine-induced myocardial infarction Ann Intern Med 118 199 200 8417637 1:STN:280:DyaK3s7htFKiuw%3D%3D (Pubitemid 23034806)
2. L Iffy W TenHove G Frisoli 1986 Acute myocardial infarction in the puerperium in patients receiving bromocriptine Am J Obstet Gynecol 155 371 372 3740157 1:STN:280:DyaL283ptlWitA%3D%3D (Pubitemid 16054877)
3. RM Herings BH Stricker 1995 Bromocriptine and suppression of postpartum lactation. The incidence of adverse cardiovascular effects in women of child-bearing age Pharm World Sci 17 133 137 7581219 10.1007/BF01872390 1:STN:280:DyaK28%2FgtlWhug%3D%3D
4. WJ Meyler 1996 Side effects of ergotamine Cephalalgia 16 5 10 8825693 10.1046/j.1468-2982.1996.1601005.x 1:STN:280:DyaK28vitlSqsA%3D%3D (Pubitemid 26050204)
5. HJ Senter AN Lieverman R Pinto 1976 Cerebral manifestations of ergotism. Report of a case and review of the literature Stroke 7 88 92 1258110 10.1161/01.STR.7.1.88 1:STN:280:DyaE287lsFSquw%3D%3D
6. P Tfelt-Hansen PR Saxena C Dahlof J Pascual M Lainez P Henry H Diener J Schoenen MD Ferrari PJ Goadsby 2000 Ergotamine in the acute treatment of migraine: a review and European consensus Brain 123 Pt 1 9 18 10611116 10.1093/brain/123.1.9 (Pubitemid 30037964)
7. EA Wammes-van der Heijden H Rahimtoola HG Leufkens CC Tijssen AC Egberts 2006 Risk of ischemic complications related to the intensity of triptan and ergotamine use Neurology 67 1128 1134 17030745 10.1212/01.wnl.0000240128.76399. fa 1:CAS:528:DC%2BD28XhtFyqtLbL (Pubitemid 44563816)
8. KM Biglan RG Holloway Jr MP McDermott IH Richard 2007 Risk factors for somnolence, edema, and hallucinations in early Parkinson disease Neurology 69 187 195 17620552 10.1212/01.wnl.0000265593.34438.00 (Pubitemid 47051724)
9. G Kleiner-Fisman DN Fisman 2007 Risk factors for the development of pedal edema in patients using pramipexole Arch Neurol 64 820 824 17420306 10.1001/archneur.64.6.noc60158 (Pubitemid 46919836)
10. DS Goldstein 2003 Dysautonomia in Parkinson's disease: neurocardiological abnormalities Lancet Neurol 2 669 676 14572735 10.1016/S1474-4422(03)00555-6 (Pubitemid 37311320)
11. KM Rose HA Tyroler CJ Nardo DK Arnett KC Light W Rosamond AR Sharrett M Szklo 2000 Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study Am J Hypertens 13 571 578 10912737 10.1016/S0895-7061(99)00257-5 1:STN:280:DC%2BD3M%2FivVOruw%3D%3D (Pubitemid 30459866)
12. ML Eigenbrodt KM Rose DJ Couper DK Arnett R Smith D Jones 2000 Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996 Stroke 31 2307 2313 11022055 10.1161/01.STR.31.10.2307 1:STN:280:DC%2BD3cvns1agsg%3D%3D
13. RM Herings A Bakker BH Stricker G Nap 1992 Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts J Epidemiol Community Health 46 136 140 1349911 10.1136/jech.46.2.136 1:STN:280:DyaK383mtVWgtQ%3D%3D
14. DA Van de Vijver BH Stricker MM Breteler RA Roos AJ Porsius A de Boer 2001 Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease Pharm World Sci 23 148 152 11599201 10.1023/A:1011807919632 (Pubitemid 32852724)
15. WG Blackard 1993 Edema-an infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs Am J Med 94 445 8097366 10.1016/0002-9343(93)90160-Q 1:STN:280:DyaK3s3jsFyksQ%3D%3D (Pubitemid 23106635)
16. R Schade F Andersohn S Suissa W Haverkamp E Garbe 2007 Dopamine agonists and the risk of cardiac-valve regurgitation N Engl J Med 356 29 38 17202453 10.1056/NEJMoa062222 1:CAS:528:DC%2BD2sXitlCgsg%3D%3D (Pubitemid 46041751)
17. R Zanettini A Antonini G Gatto R Gentile S Tesei G Pezzoli 2007 Valvular heart disease and the use of dopamine agonists for Parkinson's disease N Engl J Med 356 39 46 17202454 10.1056/NEJMoa054830 1:CAS:528:DC%2BD2sXitlCgsQ%3D%3D (Pubitemid 46041752)
18. BL Roth 2007 Drugs and valvular heart disease N Engl J Med 356 6 9 17202450 10.1056/NEJMp068265 1:CAS:528:DC%2BD2sXitlCitQ%3D%3D
19. FL Mastaglia RD Johnsen BA Kakulas 2002 Prevalence of stroke in Parkinson's disease: a postmortem study Mov Disord 17 772 774 12210874 10.1002/mds.10199 (Pubitemid 41295023)
20. KA Jellinger 2003 Prevalence of stroke in Parkinson's disease Mov Disord 18 723 724 12784283 10.1002/mds.10412 (Pubitemid 36790295)